Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
49
VMD Quote, Financials, Valuation and Earnings
Last price:
$7.41
Seasonality move
:
6.43%
Day range:
$7.40 - $7.68
52-week range:
$5.93 - $8.62
Dividend yield:
0%
P/E ratio:
22.81x
P/S ratio:
1.22x
P/B ratio:
2.15x
Volume:
153K
Avg. volume:
150.3K
1-year change:
-7.26%
Market cap:
$286.7M
Revenue:
$224.3M
EPS (TTM):
$0.33
Analysts' Opinion
-
Consensus RatingViemed Healthcare, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.00, Viemed Healthcare, Inc. has an estimated upside of 72.41% from its current price of $7.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $7.54.
Fair Value
-
According to the consensus of 2 analysts, Viemed Healthcare, Inc. has 72.41% upside to fair value with a price target of $13.00 per share.
VMD vs. S&P 500
-
Over the past 5 trading days, Viemed Healthcare, Inc. has overperformed the S&P 500 by 4.23% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Viemed Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Viemed Healthcare, Inc. has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Viemed Healthcare, Inc. reported revenues of $71.9M.
Earnings Growth
-
Viemed Healthcare, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viemed Healthcare, Inc. reported earnings per share of $0.09.
Enterprise value:
302.1M
EV / Invested capital:
1.89x
Price / LTM sales:
1.22x
EV / EBIT:
16.42x
EV / Revenue:
1.19x
PEG ratio (5yr expected):
0.80x
EV / Free cash flow:
56.10x
Price / Operating cash flow:
57.66x
Enterprise value / EBITDA:
6.60x
Gross Profit (TTM):
$146.1M
Return On Assets:
7.67%
Net Income Margin (TTM):
5.49%
Return On Equity:
10.37%
Return On Invested Capital:
9.63%
Operating Margin:
9.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $169.8M | $214.3M | $254.8M | $58M | $71.9M | |
| Gross Profit | $102.4M | $127.6M | $146.1M | $34M | $40.9M | |
| Operating Income | $13.4M | $16.5M | $18.4M | $5.2M | $7M | |
| EBITDA | $33.7M | $41.5M | $45.8M | $11.6M | $14.5M | |
| Diluted EPS | $0.23 | $0.26 | $0.33 | $0.10 | $0.09 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $47.4M | $42.9M | $35.9M | $47.7M | $50M | |
| Total Assets | $115.5M | $119.4M | $149.4M | $169.5M | $202.4M | |
| Current Liabilities | $20.2M | $20.6M | $31.6M | $36.4M | $44.2M | |
| Total Liabilities | $26.1M | $25.5M | $40.6M | $42.7M | $66.9M | |
| Total Equity | $89.4M | $93.9M | $108.8M | $126.8M | $135.5M | |
| Total Debt | $7.6M | $4.8M | $10.7M | $6.5M | $23.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $39.6M | $37.4M | $48.5M | $12.7M | $18.4M | |
| Cash From Investing | -$52M | -$29M | -$51.8M | -$5M | -$32.3M | |
| Cash From Financing | $986K | -$7.1M | $3.1M | -$5.2M | $5M | |
| Free Cash Flow | $15.9M | $3.5M | $5.4M | $1.7M | $10.7M | |
VMD
Sector
Market Cap
$286.7M
$28.3M
Price % of 52-Week High
87.52%
51.3%
Dividend Yield
0%
0%
Shareholder Yield
3.32%
-1.42%
1-Year Price Total Return
-7.26%
-17.78%
Beta (5-Year)
1.206
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$7.30
200-day SMA
Buy
Level
$6.84
Bollinger Bands (100)
Buy
Level
6.47 - 7.11
Chaikin Money Flow
Buy
Level
96.2K
20-day SMA
Buy
Level
$6.99
Relative Strength Index (RSI14)
Buy
Level
68.92
ADX Line
Buy
Level
6.23
Williams %R
Sell
Level
-12.5581
50-day SMA
Buy
Level
$6.76
MACD (12, 26)
Buy
Level
1.06
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
296.2K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.6881)
Buy
CA Score
(Annual)
Level (1.6067)
Buy
Beneish M-Score
(Annual)
Level (-2.8712)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.1824)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.
Stock Forecast FAQ
In the current month, VMD has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VMD average analyst price target in the past 3 months is $13.00.
-
Where Will Viemed Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Viemed Healthcare, Inc. share price will rise to $13.00 per share over the next 12 months.
-
What Do Analysts Say About Viemed Healthcare, Inc.?
Analysts are divided on their view about Viemed Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viemed Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Viemed Healthcare, Inc.'s Price Target?
The price target for Viemed Healthcare, Inc. over the next 1-year time period is forecast to be $13.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Viemed Healthcare, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VMD?
You can purchase shares of Viemed Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viemed Healthcare, Inc. shares.
-
What Is The Viemed Healthcare, Inc. Share Price Today?
Viemed Healthcare, Inc. was last trading at $7.41 per share. This represents the most recent stock quote for Viemed Healthcare, Inc.. Yesterday, Viemed Healthcare, Inc. closed at $7.54 per share.
-
How To Buy Viemed Healthcare, Inc. Stock Online?
In order to purchase Viemed Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VMD
Sector
P/E ratio
22.81x
23.99x
PEG ratio
0.80x
-0.01x
P/B ratio
2.15x
1.80x
Price / LTM sales
1.22x
1.59x
Growth Metrics
VMD
Sector
Revenue growth
23.98%
4.62%
Earnings growth
-8.83%
10.71%
Revenue (5-year growth)
22.82%
6.5%
Earnings forecast
$0.10
-$0.20
Profitability
VMD
Sector
Profitability FY 2024
$131.7M
$3.6M
Return on invested capital
9.63%
-31.84%
Return on assets
7.67%
-27.96%
Return on equity
10.37%
-37.47%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
VMD
Sector
Total cash
$11.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$177.1M
$78M
Long term debt
$23.5M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is up 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
